ALK and neuroblastoma: Notably, native ALK protein is expressed on the cell surface of the vast majority of neuroblastoma tumors29–31 and as an oncofetal protein, it is not expressed in somatic post-natal tissues, thereby nominating ALK as an ideal immunotherapy target.